Trump Peace Plan: A Good Diagnosis But Bad Medication

Trump Peace Plan: A Good Diagnosis But Bad Medication

Donald Trump

Israel

Palestine

The Middle East

Since the time it was unveiled in the White House on January 28, 2020, Peace to Prosperity: A Vision to Improve the Lives of the Palestinian and Israeli People or more commonly known as Trump Plan, is a non-starter. As it was being announced, two main protagonists—President Donald Trump and Prime Minister Benjamin Netanyahu—were fighting for their political survival. The US Senate was deliberating the House Resolution to impeach President Trump and moments before the White House event, Israel's Attorney General Avichai Mandelblit formally filed charges of corruption against Netanyahu in a court in Jerusalem. However, both leaders managed to weather the political storm; if the Senate acquitted the US President, the inconclusive March 2, 2020, Knesset elections—the third within a year—injected fresh hopes for the Likud leader. However, even the little hopes people had about the Plan were firmly buried in the pandemic coronavirus and the unfolding worldwide health emergency, mounting human casualties, and the impending global economic collapse.

Kumaraswamy, P.R.

CLAWS Journal; Vol. 13 No. 1 (2020): Summer 2020; 48-64

2319-5177

Centre For Land Warfare Studies (CLAWS), New Delhi, India

2020-06-30

Copyright (c) 2020 Center For Land Warfare Studies (CLAWS), New Delhi, India

https://ojs.indrastra.com/index.php/clawsjournal/copyright-transfer-form

application/pdf

eng

info:eu-repo/semantics/article

info:eu-repo/semantics/publishedVersion

Peer-reviewed Article